Docusign Shares Jump on Strong Outlook: Is It Too Late to Buy the Stock?

Docusign (DOCU) reported robust fiscal Q2 2026 results, with revenue rising 9% to $800.6 million and billings surging 13% to $818 million, both surpassing analyst expectations and company guidance. This strong performance was primarily driven by increasing momentum in its new Intelligent Agreement Management (IAM) platform, prompting Docusign to raise its full-year revenue and billings outlook. Despite a post-earnings stock rally, DOCU is considered attractively valued at current levels, underpinned by consistent cash flow generation and promising early traction for its strategic shift towards comprehensive agreement solutions.

Analysis

Docusign reported a solid fiscal second quarter for 2026, demonstrating progress in its strategic pivot and operational execution. Revenue increased 9% year-over-year to $800.6 million, while billings, a key indicator of future revenue, grew a more robust 13% to $818 million, significantly outperforming the company's guidance. This performance was driven by early success with its new Intelligent Agreement Management (IAM) platform, with over half of account representatives closing at least one IAM deal during the quarter. Key customer metrics also showed strength, with dollar revenue retention improving to 102% and the number of large customers (spending over $300,000) growing 7%. Despite a 5% decline in adjusted EPS to $0.92 due to cloud migration costs, the result still surpassed analyst expectations. The company's financial position remains strong, generating $217.6 million in free cash flow and ending the quarter with $1.1 billion in cash and no debt after repurchasing $201.5 million in stock. In a sign of confidence, management raised its full-year guidance for revenue and billings. However, the Q3 billings growth forecast of approximately 5% at the midpoint suggests a potential near-term deceleration from the strong 13% growth seen in Q2.

Key Decisions for Investors

• Given the strong Q2 performance, raised full-year guidance, and early traction in the higher-value Intelligent Agreement Management platform, the current valuation at under 5x price-to-sales may present a favorable entry point for investors confident in the strategic pivot.
• Investors should closely monitor billings growth in subsequent quarters, as the midpoint of Q3 guidance implies a material deceleration to 5% growth from 13% in Q2, which could signal a risk to future revenue momentum if the trend persists.
• The successful execution of the IAM platform strategy is the central pillar of the investment thesis; therefore, tracking key performance indicators such as IAM adoption rates and its contribution to subscription revenue will be critical for assessing future growth potential.
• The company's strong balance sheet, with $1.1 billion in cash and no debt, and consistent free cash flow generation provide significant financial flexibility for share repurchases and strategic investments, offering a degree of stability for the stock.